C10010685 / invoice 10000

Species:CANINE
Breed:French Bulldog
Age (years):2
Diagnosis or signs:itchy skin
Consult notes

Animal clinical history (3 most recent)

2026-03-10T00:00:00Z 11:42 AM
HISTORY:  Presented for vaccination and cytopoint.  The owner enquired about Cytopoint injection for licking is currently licking his feet again. The owner recently changed parasite prevention from nexgard spectra to bravecto so needs a proheart injection Current meds: BravectoVaccination: Proheart SR-12, C4 and oral BB administered.Parasite Prevention: Recently switched from nexgard spectra to bravectoPre-existing conditions: noneAccess to toxins eg. Rodenticide: none EXAMINATION:Body Condition Score: 5/9Pain Scale (0-4): 0/4Hydration status (%): hydration clinically adequateCardiovascular: cardiac auscultation normal, normal rhythm, pulse pressures normal and synchronousRespiratory: thoracic auscultation clear sounds bilaterally, respiratory effort normal, no nasal dischargeNeurological: neurologically no significant findingsMusculoskeletal: ambulating normally, no palpable neck, spine, limb or joint painGastrointestinal:- Oral: normal, no mouth pain, dental score (1-4):not graded- Abdominal: no detectable pain on abdominal palpation- Rectal: not performedUrinary: NSFReproductive: NSFIntegument/Ears: there is erythema present between toes - due for cytopoitn so this should help with pruritisLymph Nodes: NSFEyes: NSFDemeanour/Behaviour: not discussed PROBLEM LIST:- Due for vaccination- Due for heartworm prevention DIFFERENTIAL DIAGNOSIS/ DIAGNOSIS:Not discussed. DIAGNOSTICS:None ASSESSMENT:  Presented for a routine health check and vaccination. The examination revealed no significant abnormalities. Parasite prevention was discussed, and the recent change from nexgard spectra to bravectoTREATMENT:  - Proheart SR-12 administered for heartworm prevention.C4 and oral BBCytopoint 20mg PLAN:- Continue with routine parasite prevention.- Re-evaluation as needed or for annual health check and vaccination.- Home into owner's care. CLIENT COMMUNICATION:Discussed the administration of the Proheart SR-12 vaccination. Confirmed that Cytopoint can be administered concurrently with vaccinations if required in the future for skin issues. Discussed the current parasite prevention protocol. No concerns were raised.    Vital Signs    Weight: 10;       

Previous claim history (10)

DateClaim #Diagnosis
2025-02-07C8299954HYPERSENSITIVITY (ALLERGIC) SKIN DISORDER
2024-12-17C8085645HISTIOCYTOMA (CUTANEOUS, SKIN)
2024-12-09C8048577HISTIOCYTOMA (CUTANEOUS, SKIN)
2024-12-02C8018609PRURITUS - PRESENTING COMPLAINT
2024-08-19C7599150DESEXING
2024-07-19C7481890EAR INFECTION
2024-07-04C7425692DERMATITIS - ATOPIC
2024-04-03C7066875PYODERMA
2024-03-19C7063914FLEA/TICK/WORM CONTROL
2024-03-19C7063914Grooming

Line items(lines with upstream diagnosis are skipped by the model)

LinetstarcAmountDateUpstream diagnosis
10000tstarc_consultation7.202026-03-10
20000tstarc_consultation12.402026-03-10
30000tstarc_consultation80.402026-03-10
40000tstarc_skin_medication_-_cytopoint179.202026-03-10
50000tstarc_vaccination_(canine)32.202026-03-10
upstreamDSTP_routine_care_-_vaccinations_or_health_checks
60000tstarc_vaccination_(canine)33.802026-03-10
upstreamDSTP_routine_care_-_vaccinations_or_health_checks
70000tstarc_heartworm_control123.202026-03-10
upstreamDSTP_routine_care_-_heartworm_control

UPM+

  • DG02319HYPERSENSITIVITY (ALLERGIC) SKIN DISORDERDSTP_skin_-_allergic_disorder

Variant (sleepy_king)

HYPERSENSITIVITY DISORDER (ALLERGY)
DSTP_skin_-_allergic_disorder
Conf: 0.720
Threshold: 0.38
Above:
Correct?